Literature DB >> 16417033

Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data.

Jennifer Seed1, Edward W Carney, Richard A Corley, Kevin M Crofton, John M DeSesso, Paul M D Foster, Robert Kavlock, Gary Kimmel, James Klaunig, M E Meek, R Julian Preston, William Slikker, Sonia Tabacova, Gary M Williams, Jeanette Wiltse, R Thomas Zoeller, Penelope Fenner-Crisp, Dorothy E Patton.   

Abstract

A complete mode of action human relevance analysis--as distinct from mode of action (MOA) analysis alone--depends on robust information on the animal MOA, as well as systematic comparison of the animal data with corresponding information from humans. In November 2003, the International Life Sciences Institute's Risk Science Institute (ILSI RSI) published a 2-year study using animal and human MOA information to generate a four-part Human Relevance Framework (HRF) for systematic and transparent analysis of MOA data and information. Based mainly on non-DNA-reactive carcinogens, the HRF features a "concordance" analysis of MOA information from both animal and human sources, with a focus on determining the appropriate role for each MOA data set in human risk assessment. With MOA information increasingly available for risk assessment purposes, this article illustrates the further applicability of the HRF for reproductive, developmental, neurologic, and renal endpoints, as well as cancer. Based on qualitative and quantitative MOA considerations, the MOA/human relevance analysis also contributes to identifying data needs and issues essential for the dose-response and exposure assessment steps in the overall risk assessment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417033     DOI: 10.1080/10408440591007133

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  24 in total

1.  Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.

Authors:  Jing Yuan; Ken Chih-Chien Cheng; Ronald L Johnson; Ruili Huang; Sittiporn Pattaradilokrat; Anna Liu; Rajarshi Guha; David A Fidock; James Inglese; Thomas E Wellems; Christopher P Austin; Xin-zhuan Su
Journal:  Science       Date:  2011-08-05       Impact factor: 47.728

Review 2.  Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Authors:  Ronald N Hines; Dana Sargent; Herman Autrup; Linda S Birnbaum; Robert L Brent; Nancy G Doerrer; Elaine A Cohen Hubal; Daland R Juberg; Christian Laurent; Robert Luebke; Klaus Olejniczak; Christopher J Portier; William Slikker
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

Review 3.  Case examples of an evaluation of the human relevance of the pyrethroids/pyrethrins-induced liver tumours in rodents based on the mode of action.

Authors:  Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2018-01-16       Impact factor: 3.524

4.  Screening for human urinary bladder carcinogens: two-year bioassay is unnecessary.

Authors:  Samuel M Cohen
Journal:  Toxicol Res (Camb)       Date:  2018-01-23       Impact factor: 3.524

5.  Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening.

Authors:  Ruili Huang; Noel Southall; Ming-Hsuang Cho; Menghang Xia; James Inglese; Christopher P Austin
Journal:  Chem Res Toxicol       Date:  2008-02-19       Impact factor: 3.739

Review 6.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

7.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.

Authors:  Richard Judson; Robert Kavlock; Matthew Martin; David Reif; Keith Houck; Thomas Knudsen; Ann Richard; Raymond R Tice; Maurice Whelan; Menghang Xia; Ruili Huang; Christopher Austin; George Daston; Thomas Hartung; John R Fowle; William Wooge; Weida Tong; David Dix
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

8.  Editor's Highlight: Analysis of the Effects of Cell Stress and Cytotoxicity on In Vitro Assay Activity Across a Diverse Chemical and Assay Space.

Authors:  Richard Judson; Keith Houck; Matt Martin; Ann M Richard; Thomas B Knudsen; Imran Shah; Stephen Little; John Wambaugh; R Woodrow Setzer; Parth Kothiya; Jimmy Phuong; Dayne Filer; Doris Smith; David Reif; Daniel Rotroff; Nicole Kleinstreuer; Nisha Sipes; Menghang Xia; Ruili Huang; Kevin Crofton; Russell S Thomas
Journal:  Toxicol Sci       Date:  2016-05-20       Impact factor: 4.849

Review 9.  Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity.

Authors:  Anna Bal-Price; Pamela J Lein; Kimberly P Keil; Sunjay Sethi; Timothy Shafer; Marta Barenys; Ellen Fritsche; Magdalini Sachana; M E Bette Meek
Journal:  Neurotoxicology       Date:  2016-05-17       Impact factor: 4.294

10.  The Key Events Dose-Response Framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds.

Authors:  Elizabeth Julien; Alan R Boobis; Stephen S Olin
Journal:  Crit Rev Food Sci Nutr       Date:  2009-09       Impact factor: 11.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.